Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostatic Neoplasms × Metformin × Clear all

Phase

Phase 2 21 Phase 3 2 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 36 Anovulation 8 Infertility 7 Obesity 6 Insulin Resistance 6 Non-alcoholic Fatty Liver Disease 2 Hirsutism 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Nodule 1 Racism 1 Prostatic Neoplasms 1 Overweight 1 Mouth Neoplasms 1 Metabolic Syndrome 1 Hyperandrogenism 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1 Dyslipidemias 1 Diabetes, Gestational 1 Diabetes Mellitus, Type 2 1 Breast Cancer Female 1 Body Weight 1 Amenorrhea 1 Acne Vulgaris 1

Interventions

Zoledronic Acid 9 Leuprolide 8 luprolide acetate gel depot 5 enzalutamide 5 bicalutamide 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 Triptorelin Pamoate 4 Dutasteride 4 darolutamide 3 Magnetic Resonance Spectroscopy 3 Goserelin 3 Flutamide 3 Androgen Antagonists 3 Abiraterone Acetate 3 fluciclovine F-18 2 Sodium Chloride 2 Propofol 2 Prednisone 2 Prednisolone 2 Gonadotropin-Releasing Hormone 2 Finasteride 2 Dexamethasone 2 Desflurane 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 testosterone 17 beta-cypionate 1 semaglutide 1 polyethylene glycol 3350 1 pegylated granulocyte colony-stimulating factor, human 1 pasireotide 1 gadoteridol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02511665 2015-07-30

METAL

Guy's and St Thomas' NHS Foundation Trust

Phase 4 Unknown

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡